Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
Earnings Data
Report Date
May 19, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.1Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 31, 2025
|% Change Since: 143.74%
|Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Positive
The call highlighted strong financial growth, successful arbitration outcomes, and effective debt management, despite challenges posed by the No Surprises Act and the operational burden of the arbitration process.Company Guidance
During the Nutex Health Fourth Quarter 2024 Earnings Call, significant financial metrics were highlighted, demonstrating the company's robust performance. Total revenue for the full year reached $479.9 million, marking a 94% increase from 2023's $247.6 million. The adjusted EBITDA saw an impressive surge from $10.8 million in 2023 to $123.7 million in 2024, reflecting a growth of over 1,000%. Net income also improved, reaching $52 million in 2024, compared to a loss of $46 million the previous year. Patient volume rose by 17%, with total hospital visits increasing from 144,000 in 2023 to 168,000 in 2024, driven by a 6.5% growth from mature hospitals. Despite opening four new hospitals, long-term debt was efficiently managed, increasing only slightly in the current portion from $10.8 million in 2023 to $14 million in 2024, while net long-term debt decreased from $26 million to $22 million. These metrics underscore Nutex Health's successful expansion strategy and fiscal discipline amidst challenges like the No Surprises Act and its arbitration process.Exceptional Revenue Growth
For the full year of 2024, total revenue reached $479.9 million, up 94% from $247.6 million in 2023.
Significant EBITDA Increase
Adjusted EBITDA increased from $10.8 million in 2023 to $123.7 million in 2024, up over 1,000%.
Net Income Turnaround
Full year 2024 net income was $52 million compared to a loss of $46 million in 2023.
Hospital Expansion
Opened four new hospitals in 2024, bringing the total to 24 hospitals across 11 states.
Debt Management
Long-term debt decreased from $26 million in 2023 to $22 million in 2024, emphasizing fiscal responsibility.
Arbitration Process Success
Achieved an 80% win rate in arbitration, resulting in significant revenue recovery, with a 150% to 250% increase in reimbursement on the facility collection side.
---
NUTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NUTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 31, 2025 | $47.03 | $71.40 | +51.82% |
| Nov 07, 2024 | $28.89 | $31.56 | +9.24% |
| Aug 08, 2024 | $7.90 | $10.10 | +27.85% |
| May 08, 2024 | $6.47 | $6.60 | +2.01% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Clinigence Holdings (NUTX) report earnings?
Clinigence Holdings (NUTX) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
What is Clinigence Holdings (NUTX) earnings time?
Clinigence Holdings (NUTX) earnings time is at May 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUTX EPS forecast?
NUTX EPS forecast for the fiscal quarter 2025 (Q1) is -0.15.
---